USANA HEALTH SCIENCES INC
For the period ended Aug 4, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 4, 2026 · Filed Aug 4, 2026
USNA$13.63-1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Quarter ended | ||
|---|---|---|
| July 04, 2026 | June 28, 2025 | |
| Net (loss) earnings attributable to USANA (GAAP) | $(21,382) | $9,655 |
| Earnings (loss) per common share - Diluted | $(1.16) | $0.52 |
| Weighted Average common shares outstanding - Diluted | 18,486 | 18,536 |
| Adjustment to net (loss) earnings: | ||
| Transaction, integration and transition costs - Hiya | $2 | $115 |
| Inventory step-up - Hiya | — | 544 |
| Estimated preliminary impairment | 29,137 | — |
| Amortization of intangible assets - Hiya | 4,456 | 4,456 |
| Adjustments to net (loss) earnings attributable to noncontrolling interest | (7,106) | (1,057) |
| Income tax effect of adjustments to net (loss) earnings | (6,346) | — |
| Adjusted net (loss) earnings attributable to USANA | $(1,239) | $13,713 |
| Adjusted (loss) earnings per common share - Diluted | $(0.07) | $0.74 |
| Weighted average common shares outstanding - Diluted | 18,486 | 18,536 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.